Sign inJoin waitlistJoin the waitlist

John Sarantopoulos

Associate Professor · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

Credentials: · ·

History

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present

Institute for Drug Development
2004–2006
Medical Oncology
2001–2003
University of Calgary
1997–2000
Doctor of Medicine
1993–1997

Research

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
The Lancet Oncology · 2020 · 392 citations
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
Clinical Cancer Research · 2021 · 313 citations
Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1
Journal of Clinical Oncology · 2009 · 259 citations

Devalingam Mahalingam
19 papers
AM
Alain Mita
17 papers
MM
Monica Mita
14 papers
AT
Anthony Tolcher
9 papers
Craig Lockhart
8 papers
JN
John Nemunaitis
7 papers
Andrew Brenner
6 papers
CT
Christopher Takimoto
6 papers
KS
Kamlesh Sankhala
6 papers
Geoffrey Shapiro
5 papers
Patricia LoRusso
5 papers
Sukeshi Arora
5 papers · 1 as a fellow

Grants

Texas EXperimental Cancer Therapeutics Network - TEX CTN
National Cancer Institute · UM1
PI · $12.5M · University of Tx Md Anderson Can Ctr
2014–2027
Mays Cancer Center at UT San Antonio Health Science Center
National Cancer Institute · P30
Project lead · $66.1K · University of Texas Hlth Science Center
2009–2014
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1K · University of Texas Hlth Science Center
2008

Clinical trials

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
Principal investigator · Recruiting · Phase 1
Lei Zheng
2026–2028
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
Principal investigator · Completed · Phase 1
Incuron
2013–2019
Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment
Principal investigator · Withdrawn · Phase 1
CTI BioPharma
2012–2018
A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas
Principal investigator · Terminated · Phase 1
Celgene
2011